发明名称 Molecular targets for ALS and related disorders
摘要 Provided herein are compositions and methods for diagnosis, risk assessment, research, and therapy related to amyotrophic lateral sclerosis (ALS) and ALS-related disorders. In particular, the present invention relates to mutations in the UBQLN2 gene that cause dominantly inherited chromosome X-linked ALS and ALS/dementia.
申请公布号 US9173897(B2) 申请公布日期 2015.11.03
申请号 US201113313884 申请日期 2011.12.07
申请人 NORTHWESTERN UNIVERSITY 发明人 Siddique Teepu;Chen Wenjie;Deng Han-Xiang;Yang Yi
分类号 C12Q1/68;C12P19/34;A61K31/713 主分类号 C12Q1/68
代理机构 Foley & Lardner LLP 代理人 Foley & Lardner LLP
主权项 1. A method of detecting a mutation in a UBQLN2 nucleic acid in a human sample, comprising: (a) contacting a UBQLN2 nucleic acid in a human sample with an oligonucleotide that specifically hybridizes to one or more missense mutations in a UBQLN2 nucleic acid, wherein the one or more missense mutations results in a substitution of a proline in the 12 P-X-X tandem repeats encoded by the UBQLN2 gene; and (b) detecting hybridization of the oligonucleotide with the UBQLN2 nucleic acid under specific hybridization conditions, wherein detection of hybridization is indicative of a mutation in the UBQLN2 nucleic acid.
地址 Evanston IL US